Literature DB >> 17705062

Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures.

Benoit J M Pirotte1, Alphonse Lubansu, Michael Bruneau, Chakir Loqa, Nathalie Van Cutsem, Jacques Brotchi.   

Abstract

OBJECTIVE: The objective of this study was to evaluate whether the rigid application of a sterile protocol for shunt placement was applicable on a routine basis and allowed the reduction of shunt infections (SI) in children.
MATERIALS AND METHODS: Since 2001, a rigid sterile protocol for shunt placement in children using neither antibiotic-impregnated catheters nor laminar airflow was prospectively applied at Erasme Hospital, Brussels, Belgium. For assessing the protocol efficacy before continuation, we preliminarily analyzed the results of the first 100 operated children (43 females, 57 males, 49 aged <12 months; 115 consecutive shunt placement/revision procedures). All procedures were performed by the same senior surgeon, one assistant, one circulating nurse, one anesthesiologist. The sterile protocol was rigidly imposed to these four staff members: uniformed surgical technique; limited implant and skin edge manipulation; minimized human circulation in the room; scheduling surgery as first morning operation; avoiding postoperative cerebrospinal fluid (CSF) leak; double gloving; procedures of less than 30-min duration; systemic antibiotics prophylaxis. We analyzed separately: (1) children carrying an increased risk of SI (n = 38) due to preoperative external ventricular drainage, CSF leak, meningitis, glucocorticoids, chemotherapy; (2) children aged <12 months; (3) procedures for shunt revision.
RESULTS: Errors in protocol application were recorded in 71/115 procedures. They were mainly done by non-surgical staff, decreased with time and were medically justified in some young children. Surprisingly, no SI occurred (follow-up, 4 to 70 months). One child developed an appendicitis with peritonitis (Streptococcus faecalis) after 6 months. No SI was found. After peritonitis was cured, shunt reinsertion was uneventful.
CONCLUSION: These preliminary results suggest that a uniform and drastic sterile surgical technique for shunt placement: (1) can be rigidly applied on a routine basis; (2) can lower the early SI rate below 1%; (3) might have a stronger impact to reduce SI than using antibiotic-impregnated catheters and optimizing the operative environment such as using laminar airflow and reducing the non-surgical staff. This last issue will be evaluated further in the present ongoing protocol.

Entities:  

Mesh:

Year:  2007        PMID: 17705062     DOI: 10.1007/s00381-007-0415-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  42 in total

1.  Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters.

Authors:  Ananthababu Pattavilakom; Despina Kotasnas; Tony M Korman; Chris Xenos; Andrew Danks
Journal:  Neurosurgery       Date:  2006-05       Impact factor: 4.654

2.  Reflections on shunt infection.

Authors:  Paul M Kanev; Jonas M Sheehan
Journal:  Pediatr Neurosurg       Date:  2003-12       Impact factor: 1.162

3.  Management of shunt infections: a multicenter pilot study.

Authors:  John R W Kestle; Hugh J L Garton; William E Whitehead; James M Drake; Abhaya V Kulkarni; D Douglas Cochrane; Cheryl Muszynski; Marion L Walker
Journal:  J Neurosurg       Date:  2006-09       Impact factor: 5.115

4.  Effect of surface proteins on Staphylococcus epidermidis adhesion and colonization on silicone.

Authors:  Haiying Tang; Anfeng Wang; Xuemei Liang; Ting Cao; Steven O Salley; James P McAllister; K Y Simon Ng
Journal:  Colloids Surf B Biointerfaces       Date:  2006-05-02       Impact factor: 5.268

5.  Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus.

Authors:  S Tuli; J Drake; J Lawless; M Wigg; M Lamberti-Pasculli
Journal:  J Neurosurg       Date:  2000-01       Impact factor: 5.115

6.  Subcutaneous ventricular catheter reservoir and ventriculoperitoneal drain-related infections in preterm infants and young children.

Authors:  N Bruinsma; E E Stobberingh; M J Herpers; J S Vles; B J Weber; D A Gavilanes
Journal:  Clin Microbiol Infect       Date:  2000-04       Impact factor: 8.067

7.  Biofilm formation by Propionibacterium acnes on biomaterials in vitro and in vivo: impact on diagnosis and treatment.

Authors:  Roger Bayston; Waheed Ashraf; Robert Barker-Davies; Emily Tucker; Rhys Clement; Juliet Clayton; Brian J C Freeman; Bryar Nuradeen
Journal:  J Biomed Mater Res A       Date:  2007-06-01       Impact factor: 4.396

8.  CSF shunt infections in children.

Authors:  U Kontny; B Höfling; P Gutjahr; D Voth; M Schwarz; H J Schmitt
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

9.  Predictors of death in pediatric patients requiring cerebrospinal fluid shunts.

Authors:  Sagun Tuli; Jayshree Tuli; James Drake; Julian Spears
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

10.  Ventricular shunting for hydrocephalus in children: patients, procedures, surgeons and institutions in English Canada, 1989-2001.

Authors:  D D Cochrane; J Kestle
Journal:  Eur J Pediatr Surg       Date:  2002-12       Impact factor: 2.191

View more
  19 in total

Review 1.  Cerebrospinal fluid diversion devices and infection. A comprehensive review.

Authors:  R Gutiérrez-González; G R Boto; A Pérez-Zamarrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

Review 2.  Ventricular shunt infections: immunopathogenesis and clinical management.

Authors:  Yenis Gutierrez-Murgas; Jessica N Snowden
Journal:  J Neuroimmunol       Date:  2014-08-13       Impact factor: 3.478

3.  Predicting ventriculoperitoneal shunt infection in children with hydrocephalus using artificial neural network.

Authors:  Zohreh Habibi; Abolhasan Ertiaei; Mohammad Sadegh Nikdad; Atefeh Sadat Mirmohseni; Mohsen Afarideh; Vahid Heidari; Hooshang Saberi; Abdolreza Sheikh Rezaei; Farideh Nejat
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

Review 4.  Evidence-based interventions to reduce shunt infections: a systematic review.

Authors:  Nehaw Sarmey; Varun R Kshettry; Michael F Shriver; Ghaith Habboub; Andre G Machado; Robert J Weil
Journal:  Childs Nerv Syst       Date:  2015-02-17       Impact factor: 1.475

5.  Real-time ultrasound guidance for ventricular catheter placement in pediatric cerebrospinal fluid shunts.

Authors:  Thomas Beez; Sevgi Sarikaya-Seiwert; Hans-Jakob Steiger; Daniel Hänggi
Journal:  Childs Nerv Syst       Date:  2015-01-07       Impact factor: 1.475

6.  Risk factors for surgical site infection following nonshunt pediatric neurosurgery: a review of 9296 procedures from a national database and comparison with a single-center experience.

Authors:  Brandon Sherrod; Anastasia Arynchyna; James Johnston; Curtis Rozzelle; Jeffrey Blount; W. Jerry Oakes; Brandon Rocque
Journal:  J Neurosurg Pediatr       Date:  2017-02-10       Impact factor: 2.375

Review 7.  Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment concepts.

Authors:  Shenandoah Robinson
Journal:  J Neurosurg Pediatr       Date:  2012-03       Impact factor: 2.375

Review 8.  Central Nervous System Device Infections.

Authors:  Rodrigo Hasbun
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.725

9.  Analysis of factors affecting ventriculoperitoneal shunt survival in pediatric patients.

Authors:  Farid Khan; Muhammad Shahzad Shamim; Abdul Rehman; Muhammad Ehsan Bari
Journal:  Childs Nerv Syst       Date:  2013-01-08       Impact factor: 1.475

10.  Role of ventriculoperitoneal shunt valve design in the treatment of pediatric hydrocephalus--a single center study of valve performance in the clinical setting.

Authors:  Thomas Beez; Sevgi Sarikaya-Seiwert; Lina Bellstädt; Mario Mühmer; Hans-Jakob Steiger
Journal:  Childs Nerv Syst       Date:  2013-07-31       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.